These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19808298)

  • 21. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
    Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
    J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
    Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
    J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between inflammation, arterial stiffness, oxidized LDL and cardiovascular disease in Finnish men with metabolic syndrome - a 15-year follow-up study.
    Saarinen HJ; Lahtela J; Mähönen P; Palomäki A;
    BMC Cardiovasc Disord; 2024 Mar; 24(1):162. PubMed ID: 38491429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults.
    Van Guilder GP; Hoetzer GL; Greiner JJ; Stauffer BL; Desouza CA
    Obesity (Silver Spring); 2006 Dec; 14(12):2127-31. PubMed ID: 17189537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome.
    Ahonen TM; Saltevo JT; Kautiainen HJ; Kumpusalo EA; Vanhala MJ
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):285-91. PubMed ID: 21093230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyżycka E; Bukowska H; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Postepy Hig Med Dosw (Online); 2016 Feb; 70():56-66. PubMed ID: 26864064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
    Haider AW; Larson MG; Franklin SS; Levy D;
    Ann Intern Med; 2003 Jan; 138(1):10-6. PubMed ID: 12513039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
    Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
    Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between metabolic syndrome, cardiometabolic risk factors and inflammatory markers in a Tehranian population: the Tehran Lipid and Glucose Study.
    Zarkesh M; Faam B; Daneshpour MS; Azizi F; Hedayati M
    Intern Med; 2012; 51(24):3329-35. PubMed ID: 23257516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Markers of Proinflammatory Phenotype and Beige Adipogenesis with Metabolic Syndrome in Chinese Centrally Obese Adults.
    Leung WKC; Yu AP; Lai CWK; Siu PM
    J Diabetes Res; 2018; 2018():8956509. PubMed ID: 29670915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes.
    Lee HM; Zhao Y; Liu MA; Yanez D; Carnethon M; Graham Barr R; Wong ND
    Clin Cardiol; 2018 Jul; 41(7):959-965. PubMed ID: 29797803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome.
    Ding Y; Li S; Ma RL; Guo H; Zhang J; Zhang M; Liu J; Guo S
    Clin Biochem; 2015 May; 48(7-8):503-7. PubMed ID: 25700597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Hypertension; 2005 Jan; 45(1):69-74. PubMed ID: 15569851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Dietary Inflammatory Index, C-Reactive Protein and Metabolic Syndrome: A Cross-Sectional Study.
    Ren Z; Zhao A; Wang Y; Meng L; Szeto IM; Li T; Gong H; Tian Z; Zhang Y; Wang P
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29954070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-Specific Associations Between Complement Component 3 and Component 4 Levels and Metabolic Syndrome in an Adult Population.
    Meng G; Li H; Li Y; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Gu Y; Su Q; Fang L; Yang H; Yu F; Shi H; Sun S; Wang X; Zhou M; Jia Q; Song K; Chang H; Wu Y; Niu K
    Metab Syndr Relat Disord; 2018 Apr; 16(3):143-149. PubMed ID: 29596043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of ceruloplasmin for metabolic syndrome in adolescents.
    González-Jiménez E; Schmidt-Riovalle J; Sinausía L; Carmen Valenza M; Perona JS
    Biofactors; 2016; 42(2):163-70. PubMed ID: 27083758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Syndrome and Inflammation from Young to Mid-Adulthood and Subclinical Kidney Damage in Middle-Aged Australians.
    Liu C; Tian J; Jose MD; Dwyer T; Venn AJ
    Metab Syndr Relat Disord; 2023 Oct; 21(8):460-467. PubMed ID: 37579129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.